Axogen Inc
$ 37.23
-3.30%
20 Apr - close price
- Market Cap 1,998,061,000 USD
- Current Price $ 37.23
- High / Low $ 39.08 / 37.06
- Stock P/E N/A
- Book Value 2.73
- EPS -0.34
- Next Earning Report 2026-04-28
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.02 %
- ROE -0.14 %
- 52 Week High 39.99
- 52 Week Low 9.22
About
AxoGen, Inc., develops and markets surgical solutions for physical damage or transection of peripheral nerves. The company is headquartered in Alachua, Florida.
Analyst Target Price
$41.22
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-03-03 | 2025-10-29 | 2025-08-05 | 2025-04-30 | 2025-02-25 | 2024-11-07 | 2024-08-08 | 2024-05-02 | 2024-03-05 | 2023-11-07 | 2023-08-07 | 2023-05-09 |
| Reported EPS | 0.07 | 0.12 | 0.12 | -0.02 | 0.07 | 0.07 | 0.05 | -0.06 | -0.06 | 0.01 | -0.03 | -0.1 |
| Estimated EPS | 0.0586 | 0.07 | 0.06 | 0.016 | 0.03 | 0.01 | -0.04 | -0.07 | -0.1 | -0.06 | -0.13 | -0.14 |
| Surprise | 0.0114 | 0.05 | 0.06 | -0.036 | 0.04 | 0.06 | 0.09 | 0.01 | 0.04 | 0.07 | 0.1 | 0.04 |
| Surprise Percentage | 19.4539% | 71.4286% | 100% | -225% | 133.3333% | 600% | 225% | 14.2857% | 40% | 116.6667% | 76.9231% | 28.5714% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-04-28 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | -0.17 |
| Currency | USD |
Previous Dividend Records
| Jan 1970 | Jan 1970 | |
|---|---|---|
| Payment Date | None | None |
| Amount | $1.0 | $0.06 |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: AXGN
2026-04-21 00:40:13
Certain options of Axogen, Inc. are under a 90-day lock-up agreement, which began on January 21, 2026, and is set to expire on April 21, 2026. This agreement restricts the company's directors and executive officers from selling or transferring shares during this period without prior consent from the underwriters. The purpose is to maintain stability following an offering.
2026-04-19 15:38:49
Axogen Inc. (NASDAQ: AXGN) demonstrates strong sentiment across all time horizons, supporting an overweight bias. AI models have identified three distinct trading strategies with favorable risk-reward setups, including an exceptional 58.3:1 ratio for a potential 16.4% gain. The article highlights specific entry, target, and stop-loss zones for position trading, momentum breakout, and risk hedging strategies.
2026-04-17 01:39:37
Axogen Inc. stock reached a new 52-week high of $36.21, reflecting a 123% return over the past year and a 108% surge in the last six months, driven by strong revenue growth and investor confidence in its nerve repair solutions. Despite this peak performance, an InvestingPro analysis suggests the stock is currently overvalued. The company recently surpassed Q4 2025 earnings and revenue expectations, and Citizens reiterated a "Market Outperform" rating with a $42.00 price target.
2026-04-16 19:56:00
Axogen Inc. (AXGN) stock reached a new 52-week high of $36.21, reflecting a 123% return over the past year and a 108% surge in the last six months, driven by 20% revenue growth. Despite this impressive performance and beating recent earnings expectations, InvestingPro analysis suggests the stock is currently overvalued relative to its Fair Value. Citizens reiterated a Market Outperform rating with a $42.00 price target.
2026-04-15 00:40:00
Axogen, Inc. announced it will release its first quarter 2026 financial results on Tuesday, April 28, 2026. The company will host an investment-community conference call and webcast at 8:00 a.m. ET to discuss the results, with participation details provided for interested investors. Axogen specializes in surgical solutions for peripheral nerve function restoration and repair, offering a range of products.
2026-04-14 11:16:31
Axogen, Inc. announced that it will release its first-quarter 2026 financial results on Tuesday, April 28, 2026. Following the release, the company will host a conference call and webcast at 8:00 a.m. ET for the investment community. Investors can access the webcast and presentation slides on Axogen's website.
